Similar articles

• Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer.

  Stanislawski T, Voss RH, Lotz C, Sadovnikova E, Willemsen RA, Kuball J, Ruppert T, Bolhuis RL, Melief CJ, Huber C, Stauss HJ, Theobald M. Stanislawski T, et al. Nat Immunol. 2001 Oct;2(10):962-70. doi: 10.1038/ni1001-962. Nat Immunol. 2001. PMID: 11577350
• Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes.

  Engels B, Noessner E, Frankenberger B, Blankenstein T, Schendel DJ, Uckert W. Engels B, et al. Hum Gene Ther. 2005 Jul;16(7):799-810. doi: 10.1089/hum.2005.16.799. Hum Gene Ther. 2005. PMID: 16000062
• Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.

  Wu F, Zhang W, Shao H, Bo H, Shen H, Li J, Liu Y, Wang T, Ma W, Huang S. Wu F, et al. Cancer Lett. 2013 Oct 10;339(2):195-207. doi: 10.1016/j.canlet.2013.06.009. Epub 2013 Jun 18. Cancer Lett. 2013. PMID: 23791878
• T-cell receptor gene transfer by lentiviral vectors in adoptive cell therapy.

  Bobisse S, Zanovello P, Rosato A. Bobisse S, et al. Expert Opin Biol Ther. 2007 Jun;7(6):893-906. doi: 10.1517/14712598.7.6.893. Expert Opin Biol Ther. 2007. PMID: 17555374 Review.
• Exploiting T cell receptor genes for cancer immunotherapy.

  Xue S, Gillmore R, Downs A, Tsallios A, Holler A, Gao L, Wong V, Morris E, Stauss HJ. Xue S, et al. Clin Exp Immunol. 2005 Feb;139(2):167-72. doi: 10.1111/j.1365-2249.2005.02715.x. Clin Exp Immunol. 2005. PMID: 15654813 Free PMC article. Review.